Skip to content

Autologous Tenocyte Implantation in Patients With Chronic Achilles Tendinopathy

The Value of Autologous Tenocyte Implantation in Patients With Chronic Achilles Tendinopathy: a Double-blind Randomised Clinical Trial

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01343836
Acronym
ATI
Enrollment
90
Registered
2011-04-28
Start date
2011-04-30
Completion date
2014-06-30
Last updated
2015-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achilles Tendon Injury, Achillodynia, Tendinopathy

Keywords

autologous tenocytes, cell therapy, eccentric exercises

Brief summary

This study is designed to compare the treatment of 2 groups in patients with Achilles tendinopathy: autologous tenocytes injection in combination with exercises versus saline injection in combination with exercises

Detailed description

Overuse injury of the Achilles tendon is a common entity. When the exact origin of tendon pain is unclear, the term tendinopathy is preferred. Most accepted treatment at this moment is an eccentric exercise programme, according to the Dutch guidelines. However, a recent systematic review on the effectiveness of eccentric exercises to treat lower extremity tendinoses concluded that it is unclear whether eccentric exercises are more effective than other forms of treatment. Recent studies described new treatment strategies in tendinopathies, such as the use autologous Tenocyte Implantation (ATI). This treatment option can participate actively in tissue repair processes on cell level. The only published clinical pilot study in tendon research reported 60% improvement in all scores after 6 months follow-up.

Interventions

OTHERAutologous Tenocyte Implantation

Intratendinous ATI (autologous tenocyte injection) with eccentric exercises

OTHERSaline

Intratendinous saline injection with eccentric exercises

Sponsors

Erasmus Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Pain on palpation 2-7 cm proximal from the tendon insertion (midportion) * Symptoms \> 2 months * Age 18-55 years

Exclusion criteria

* Clinical suspicion of insertional disorders , Achilles tendon rupture, plantar flexor tenosynovitis, sural nerve pathology, peroneal subluxation * Condition of the Achilles tendon caused by medications such as quinolones and statins * Known to have the following disorders: spondylarthropathy, gout, hyperlipidemia, rheumatoid arthritis and sarcoidosis. * Antibiotics allergy (aminoglycoside group) * A condition that prevents the patients from executing an active rehabilitation programme * Patient has received an injection for this injury * Patient has received surgical intervention for this injury * Patient has already one site (left or right) included in this study * Patient does not wish, for whatever reason, to undergo one of the two treatments * Known pregnancy * Nursing women

Design outcomes

Primary

MeasureTime frameDescription
VISA-A score24 weeksa validated instrument to detect the severity of symptoms in patients with Achilles tendinopathy

Secondary

MeasureTime frameDescription
Ultrasonographic tendon repair - Ultrasonographic Tissue Characterization (UTC)24 weeksUTC provides quantitative information on tendon fiber alignment and the related ultra-structural integrity of the tendon tissue through a non-invasive approach and is used in several clinical trials in humans
Subjective patient satisfaction24 weeksPatient satisfaction will be determined by asking the patient how satisfied he/she is with the effect of the treatment in 4 possible categories: excellent / good / moderate / poor. The groups excellent and good will be regarded as successful and the groups of moderate and poor as not successful.
Returning to sports level24 weeksThe patient will be asked whether they are able to return to their sports level. It is a subdivision in 5 groups: A. No sports; B. No return in sports; C. Returning in sports but not in desired sport; D. Returning in desired sport, but not yet old level; E. Returning to old level in desired sport.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026